IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis

miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth

(2016) Yuyan Han et al.   JOURNAL OF HEPATOLOGY

miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis

(2016) Tingting Huang et al.   Molecular Cancer

Hsa-miR-375 is a predictor of local control in early stage breast cancer

(2016) Franz Zehentmayr et al.   Clinical Epigenetics

Growth and fatty acid characterization of microalgae isolated from municipal waste-treatment systems and the potential role of algal-associated bacteria in feedstock production

(2016) Kevin Stemmler et al.   PeerJ

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations

(2015) Angélique Gougelet et al.   GUT

Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma

(2015) Wei Kang et al.   Molecular Cancer

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

(2015) Razvan Cristescu et al.   NATURE MEDICINE

Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis

(2015) XiaoTian Zhang et al.   PLoS One

Insulin-Like Growth Factor-II mRNA-Binding Protein 3 Expression in Effusion Cytology: A Marker for Metastatic Adenocarcinoma Cells and a Potential Prognostic Indicator in Gastric Adenocarcinoma

(2014) Hye Jeong Kim et al.   ACTA CYTOLOGICA

IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status

(2014) Emanuel Adelino M. Damasceno et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis

(2014) Wei Kang et al.   Journal of Translational Medicine

Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma

(2014) Wei Kang et al.   Journal of Translational Medicine

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

(2014) Jing Y. Krzeszinski et al.   NATURE

Gene Ontology Consortium: going forward

(2014)   NUCLEIC ACIDS RESEARCH

ArrayExpress update—simplifying data submissions

(2014) Nikolay Kolesnikov et al.   NUCLEIC ACIDS RESEARCH

In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma

(2014) Maria Teresa Di Martino et al.   PLoS One

IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development

(2014) Lars Jønson et al.   Cell Reports

Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma

(2014) Immacolata Scognamiglio et al.   Biomed Research International

Mir-34: A New Weapon Against Cancer?

(2014) Gabriella Misso et al.   Molecular Therapy-Nucleic Acids

Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains

(2013) Kristin Wächter et al.   BIOLOGICAL CHEMISTRY

A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells

(2013) Pengcheng Bu et al.   Cell Stem Cell

IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression

(2013) Sanjoy Samanta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization

(2013) T Rivera Vargas et al.   ONCOGENE

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

(2013) Balázs Győrffy et al.   PLoS One

miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway

(2013) Weiguo Cao et al.   TUMOR BIOLOGY

Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

(2012) Jessica L. Bell et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

(2012) M. T. Di Martino et al.   CLINICAL CANCER RESEARCH

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

(2012) Paul Lochhead et al.   EUROPEAN JOURNAL OF CANCER

Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck

(2012) T. S. Clauditz et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

MicroRNA and cancer

(2012) Martin D. Jansson et al.   Molecular Oncology

MicroRNAs in metabolism and metabolic disorders

(2012) Veerle Rottiers et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer

(2012) S Samanta et al.   ONCOGENE

Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells

(2012) Arisa Ueki et al.   PLoS One

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Classification OMS 2010 des tumeurs digestives : la quatrième édition

(2011) Jean-François Fléjou   ANNALES DE PATHOLOGIE

Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis

(2011) W. Kang et al.   CLINICAL CANCER RESEARCH

Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2

(2011) Ramaswamy Suvasini et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma

(2011) Kaoru Okada et al.   JOURNAL OF SURGICAL ONCOLOGY

The use of insulin like-growth factor II messenger RNA binding protein–3 in diagnostic pathology

(2010) Jennifer J. Findeis-Hosey et al.   HUMAN PATHOLOGY

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

(2009) Dawei Li et al.   ANNALS OF SURGICAL ONCOLOGY

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma

(2008) D. Y. Chiang et al.   CANCER RESEARCH

MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1

(2008) Queenie W.–L. Wong et al.   GASTROENTEROLOGY

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

(2008) Yung-Ming Jeng et al.   HEPATOLOGY

IMP-3 is a novel progression marker in malignant melanoma

(2008) Jennifer G Pryor et al.   MODERN PATHOLOGY

Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis

(2008) B H Liu et al.   ONCOGENE